NEJM AI Grand Rounds From Bedside to Boardroom: How AI, Multi-Omics, and New Business Models Are Shaping the Biomedical Frontier with Morgan Cheatham
44 snips
Mar 19, 2025 Morgan Cheatham, a venture capitalist at Bessemer and a medical student at Brown, dives into the intersection of AI and genomic medicine. He reveals how AI is revolutionizing clinical documentation and decision-making, making medicine more precise. Morgan shares insights from his research on ChatGPT's USMLE performance and discusses the hurdles of outdated payment models in healthcare. His journey highlights the blend of medical training and venture capital, emphasizing that innovation must be supported by sustainable business strategies.
AI Snips
Chapters
Transcript
Episode notes
Barriers to AI adoption in Healthcare
- The biggest barrier in healthcare and life sciences is not technological innovation.
- The true challenge lies in aligning payment models and incentive structures to support AI advancements.
Multifaceted Morgan Cheatham
- Morgan Cheatham balances multiple roles, including vice president at Bessemer Venture Partners and medical student at Brown.
- He has worked on projects evaluating ChatGPT's performance on medical exams and researches genomics.
Formative Experiences
- Morgan Cheatham's interest in medicine started early, but his path was shaped by witnessing Epic implementation chaos.
- He designed a major around computational decision sciences, combining economics, computer science, and neuroscience.